David Halbert

Founder, Chairman and Chief Executive Officer, Caris Life Sciences

Search every verified David Halbert interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. David Halbert, founder, chairman, and CEO of Caris Life Sciences, discussed the company’s recent IPO and its work in cancer diagnostics and AI in a June 2025 interview. He stated that the company sequences every gene in DNA and mRNA for over 500,000 cancer patients, and described its AI system, called "Dean," which uses 218 algorithms to analyze patient outcomes. Halbert said the company has no competition in this area and that its Precision Oncology Alliance includes 97 members, such as Dana-Farber and MSK, with 1,000 publications completed. He also mentioned plans to sell data and drug targets to pharmaceutical companies, and described the potential market as "much, much bigger" than $150 billion. In an October 2025 interview, Halbert discussed his private golf course, Halbert National, near Granbury, Texas, which he said cost over $50 million to build. He recounted giving course designer Tom Fazio a "no budget" mandate and described the goal of making it the top Fazio course and the top course in Texas. Halbert also spoke about his career and Caris Life Sciences, saying he believes the company will become a "multi-trillion dollar company" focused on extending life, and described a "Trojan Horse strategy" of getting paid for one service while developing other products. He noted that he acted as chief scientific officer for about two years after hiring three CEOs and three CSOs in a short period.